{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T04:46:46Z","timestamp":1791694006580,"version":"4.3.4"},"reference-count":118,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Although photodynamic therapy (PDT) is a recognised treatment for the premalignant keratinocytic lesion actinic keratosis (AK) and selected superficial skin cancers, poor photosensitiser delivery, restricted light penetration and tumour hypoxia can significantly restrict its effectiveness. Recent advances in nanomedicine are extending PDT past improved transport of the photosensitiser. These approaches can also control tumour accumulation, intracellular localisation and the generation of reactive oxygen species. The degree of tumour cell damage is not the only outcome that can be influenced by these features. They can also influence tumour-cell death and immunogenic cell death (ICD)-associated danger signalling and, in selected preclinical systems, support antigen presentation and T-cell activation. Nanomedicine-enhanced PDT has increasingly been integrated with immune-checkpoint blockade and immune adjuvants in melanoma models. In selected preclinical melanoma models, these combinations have improved local tumour control and produced antitumour effects at untreated distant or metastatic sites; functional immune memory has been demonstrated only in a smaller subset of studies using tumour-rechallenge models. Nanotechnology may further address the practical limitations of conventional PDT while improving treatment precision. This is shown by skin-directed delivery, oxygen-generating systems and theranostic platforms. However, immune-related evidence remains predominantly preclinical and melanoma-based, whereas human nanomedicine evidence in AK and basal cell carcinoma (BCC) largely concerns nanoformulation-assisted PDT rather than immune modulation. Overall, the field is progressing from nanoparticle-assisted phototoxicity towards integrated photoimmunotherapy. Treatment delivery, tumour destruction and immune activation are increasingly being considered together. Together, these findings support the continued development of nanomedicine-enhanced PDT across cutaneous oncology, while emphasising that the most advanced immune and photoimmunotherapy evidence currently remains melanoma-based.<\/jats:p>","DOI":"10.3390\/ijms27198723","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:33:12Z","timestamp":1790699592000},"page":"8723","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent Advances in Nanomedicine-Enhanced Photodynamic Therapy in Cutaneous Oncology: Melanoma-Dominant Evidence for Immunogenic Cell Death and Photoimmunotherapy"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-5464","authenticated-orcid":false,"given":"Dorota","family":"Bartusik-Aebisher","sequence":"first","affiliation":[{"name":"Department of Biochemistry and General Chemistry, Medical College, Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0829-7128","authenticated-orcid":false,"given":"Izabella","family":"Wilk","sequence":"additional","affiliation":[{"name":"English Division Science Club, Medical College, Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-6570","authenticated-orcid":false,"given":"David","family":"Aebisher","sequence":"additional","affiliation":[{"name":"Department of Photomedicine and Physical Chemistry, Medical College, Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"T883","DOI":"10.1016\/j.ad.2024.03.037","article-title":"[Translated article] Dermoscopy of squamous cell carcinoma: From actinic keratosis to invasive forms","volume":"115","author":"Zaballos","year":"2024","journal-title":"Actas Dermosifiliogr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hoc.2018.09.004","article-title":"Basal cell carcinoma review","volume":"33","author":"Kim","year":"2019","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2018.08.001","article-title":"Cutaneous squamous cell carcinoma","volume":"33","author":"Waldman","year":"2019","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5694\/mja17.00284","article-title":"The incidence and multiplicity rates of keratinocyte cancers in Australia","volume":"207","author":"Pandeya","year":"2017","journal-title":"Med. J. Aust."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/pcmr.12172","article-title":"Why is melanoma so metastatic?","volume":"27","author":"Braeuer","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5694\/mja2.52404","article-title":"Changes in the incidence of melanoma in Australia, 2006\u20132021, by age group and ancestry: A modelling study","volume":"221","author":"Whiteman","year":"2024","journal-title":"Med. J. Aust."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Correia, J.H., Rodrigues, J.A., Pimenta, S., Dong, T., and Yang, Z. (2021). Photodynamic therapy review: Principles, photosensitizers, applications, and future directions. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13091332"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdv.12031","article-title":"European guidelines for topical photodynamic therapy part 1: Treatment delivery and current indications\u2014Actinic keratoses, Bowen\u2019s disease, basal cell carcinoma","volume":"27","author":"Morton","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/09546634.2019.1569752","article-title":"An update on topical photodynamic therapy for clinical dermatologists","volume":"30","author":"Nguyen","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.apsb.2016.01.007","article-title":"Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials","volume":"6","author":"Hong","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1166\/jbn.2014.1953","article-title":"Photodynamic therapy: One step ahead with self-assembled nanoparticles","volume":"10","author":"Avci","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_12","first-page":"20","article-title":"Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles","volume":"8","author":"Lee","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Huis In \u2019t Veld, R.V., Heuts, J., Ma, S., Cruz, L.J., Ossendorp, F.A., and Jager, M.J. (2023). Current challenges and opportunities of photodynamic therapy against cancer. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020330"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e001926","DOI":"10.1136\/jitc-2020-001926","article-title":"Targeting immunogenic cancer cell death by photodynamic therapy: Past, present and future","volume":"9","author":"Alzeibak","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7150\/thno.67300","article-title":"Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy","volume":"12","author":"Ji","year":"2022","journal-title":"Theranostics"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Liu, X., Liu, X., Yu, J., Bai, X., Wu, X., Guo, X., Liu, Z., and Liu, X. (2022). Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.955920"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jdv.13228","article-title":"Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: A randomised, investigator-blinded, controlled, phase III study throughout Europe","volume":"29","author":"Lacour","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1468-3083.2008.02803.x","article-title":"A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8\u201320 mm), with a 12-month follow-up","volume":"22","author":"Szeimies","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jid.2017.09.033","article-title":"Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma","volume":"138","author":"Jansen","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaad.2023.08.076","article-title":"Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen\u2019s disease: A multicenter randomized controlled trial","volume":"90","author":"Ahmady","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pdpdt.2019.03.014","article-title":"CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages","volume":"26","author":"Ji","year":"2019","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/lsm.23516","article-title":"Modified 5-aminolevulinic acid photodynamic therapy reduces pain and improves therapeutic effects in cutaneous squamous cell carcinoma mouse model","volume":"54","author":"Zeng","year":"2022","journal-title":"Lasers Surg. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.ejca.2010.02.037","article-title":"The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma","volume":"46","author":"Camerin","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Pires, L., Demidov, V., Wilson, B.C., Salvio, A.G., Moriyama, L., Bagnato, V.S., Vitkin, I.A., and Kurachi, C. (2020). Dual-agent photodynamic therapy with optical clearing eradicates pigmented melanoma in preclinical tumor models. Cancers, 12.","DOI":"10.3390\/cancers12071956"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10103-008-0539-1","article-title":"Photophysics and photochemistry of photodynamic therapy: Fundamental aspects","volume":"24","author":"Plaetzer","year":"2009","journal-title":"Lasers Med. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/php.12716","article-title":"Type I and Type II photosensitized oxidation reactions: Guidelines and mechanistic pathways","volume":"93","author":"Baptista","year":"2017","journal-title":"Photochem. Photobiol."},{"key":"ref_27","first-page":"250","article-title":"Photodynamic therapy of cancer: An update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41419-022-04851-4","article-title":"Which cell death modality wins the contest for photodynamic therapy of cancer?","volume":"13","author":"Mishchenko","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/clm.1996.14.323","article-title":"Vascular effects of photodynamic therapy","volume":"14","author":"Fingar","year":"1996","journal-title":"J. Clin. Laser Med. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2226535","DOI":"10.1080\/2162402X.2023.2226535","article-title":"Trial watch: An update of clinical advances in photodynamic therapy and its immunoadjuvant properties for cancer treatment","volume":"12","author":"Penetra","year":"2023","journal-title":"Oncoimmunology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1751-1097.2012.01229.x","article-title":"Photodynamic effects of zinc(II) phthalocyanine-loaded polymeric micelles in human nasopharynx KB carcinoma cells","volume":"89","author":"Marino","year":"2013","journal-title":"Photochem. Photobiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e202112236","DOI":"10.1002\/anie.202112236","article-title":"Clinical development of metal complexes as photosensitizers for photodynamic therapy of cancer","volume":"61","author":"Karges","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000183753","article-title":"Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy","volume":"218","author":"Gerritsen","year":"2009","journal-title":"Dermatology"},{"key":"ref_34","first-page":"7273","article-title":"Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen","volume":"62","author":"Busch","year":"2002","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Udomsak, W., Kucinska, M., Pospieszna, J., Dams-Kozlowska, H., Chatuphonprasert, W., and Murias, M. (2024). Antioxidant enzymes in cancer cells: Their role in photodynamic therapy resistance and potential as targets for improved treatment outcomes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063164"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"214816","DOI":"10.1016\/j.bioadv.2026.214816","article-title":"Polymeric-lipid hybrid liposomes co-loaded with curcumin and silver nanoparticles: A strategy for photodynamic therapy in skin cancer","volume":"184","author":"Ricken","year":"2026","journal-title":"Biomater. Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jcis.2024.07.228","article-title":"Tea polyphenols nanoparticles integrated with microneedles multifunctionally boost 5-aminolevulinic acid photodynamic therapy for skin cancer","volume":"677","author":"Wang","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.actbio.2026.04.062","article-title":"Endoplasmic reticulum-targeted photodynamic therapy synergizes with rapamycin to induce autophagic cancer cell death","volume":"217","author":"Zheng","year":"2026","journal-title":"Acta Biomater."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo, J.L., Santos, A.S., Silva, V.R.M.C., Dos Santos, L.C., Mariano, A.d.L.e.S., Flor\u00eancio, I., B\u00e1o, S.N., da Silva, S.W., Souza, P.E.N., and Azevedo, R.B. (2026). Chlorophyll-loaded castor oil nanoemulsions exhibit photodynamic therapy efficacy against B16-F10 melanoma with low cytotoxicity toward HaCaT keratinocytes. Pharmaceuticals, 19.","DOI":"10.3390\/ph19070974"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/08853282251336557","article-title":"Preparation of protoporphyrin IX loaded nanostructured lipid carriers for anticancer photodynamic therapy","volume":"40","author":"Sheng","year":"2025","journal-title":"J. Biomater. Appl."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112570","DOI":"10.1016\/j.jinorgbio.2024.112570","article-title":"Anticancer photodynamic activities of triphenylphosphine-labelled phthalocyanines and their bovine serum albumin-gold nanoparticles-complexes on melanoma A375 cell lines in vitro","volume":"256","author":"Nene","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es, M.M., Paiva, K.L.R., de Souza, I.F., Mello, V.C., Martins da Silva, I.G., Souza, P.E.N., Muehlmann, L.A., and B\u00e1o, S.N. (2024). The potential of photodynamic therapy using solid lipid nanoparticles with aluminum phthalocyanine chloride as a nanocarrier for modulating immunogenic cell death in murine melanoma in vitro. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16070941"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1021\/acsnano.4c11024","article-title":"Photosensitive hybrid \u03b3\u03b4-T exosomes for targeted cancer photoimmunotherapy","volume":"19","author":"Gao","year":"2025","journal-title":"ACS Nano"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"12751","DOI":"10.2147\/IJN.S533318","article-title":"Assessing the in vivo safety of dendrimer-based formulations used in photodynamic therapy","volume":"20","author":"Janaszewska","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Liang, X., Zhang, J., Zhang, C., Zhai, H., Yang, P., and Chen, M. (2024). Mesoporous silica coated spicules for photodynamic therapy of metastatic melanoma. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-02471-y"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.5826\/dpc.1602a6942","article-title":"Carbon dot-based photodynamic therapy for clinical treatment of nonmelanoma skin cancer","volume":"16","author":"Romero","year":"2026","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"113328","DOI":"10.1016\/j.jphotobiol.2025.113328","article-title":"Analysis of ROS dynamics based on dissolved oxygen sensing in upconversion nanoparticle-based photodynamic therapy","volume":"274","author":"Heydari","year":"2026","journal-title":"J. Photochem. Photobiol. B"},{"key":"ref_48","first-page":"560049","article-title":"Cu-Cy Nps@ZIF-8@HA-mediated photodynamic therapy for cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2026","journal-title":"Int. J. Nanomed."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"125466","DOI":"10.1016\/j.ijpharm.2025.125466","article-title":"Transdermal sequential delivery of functionalized nano-deep eutectic system for enhanced treatment of melanoma","volume":"674","author":"Xu","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e70130","DOI":"10.1002\/kjm2.70130","article-title":"Nanotechnology in skin cancer therapy: Recent progress in targeted delivery","volume":"42","author":"Yu","year":"2026","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"103103","DOI":"10.1016\/j.pdpdt.2022.103103","article-title":"Melanoma-targeted photodynamic therapy based on hypericin-loaded multifunctional P123-spermine\/folate micelles","volume":"40","author":"Campanholi","year":"2022","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12057","DOI":"10.2147\/IJN.S527082","article-title":"Bioinspired RGD-functionalized gold nanoparticles for integrin-driven interaction with melanoma cells","volume":"20","author":"Saviano","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1039\/D4RA03858D","article-title":"The phototoxic effect of a gold-antibody-based nanocarrier of phthalocyanine on melanoma monolayers and tumour spheroids","volume":"14","author":"Nkune","year":"2024","journal-title":"RSC Adv."},{"key":"ref_54","first-page":"100413","article-title":"A novel EGFR-targeted photosensitizer for the theranostics of skin cancer","volume":"10","author":"Li","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Qi, Y., Wang, Z., Wu, Y., Wu, Q., Li, C., Yu, H., Zeng, T., Wang, Y., Li, J., and Qian, H. (2026). A DNA nanoflowers-based microneedle patch for transdermal gene and photodynamic therapy against melanoma. J. Nanobiotechnol., 24.","DOI":"10.1186\/s12951-026-04095-w"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"112766","DOI":"10.1016\/j.isci.2025.112766","article-title":"Enhancing photodynamic therapy for cutaneous squamous cell carcinoma with ACP-U soluble microneedles","volume":"28","author":"Hou","year":"2025","journal-title":"iScience"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"21194","DOI":"10.1021\/jacs.5c06905","article-title":"Smart energy-storing DNA hydrogel for on-demand laser-free photoimmunotherapy of melanoma","volume":"147","author":"Zhao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/acsnano.5c21399","article-title":"Oxygen self-sufficient Ir-MnII\/III coordination-assembled nanoparticles evoke apoptosis and ferroptosis for boosting hypoxic melanoma photoimmunotherapy","volume":"20","author":"Tang","year":"2026","journal-title":"ACS Nano"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"114925","DOI":"10.1016\/j.ejpb.2025.114925","article-title":"Oxygenated collagenase nanoliposomes for deep photodynamic therapy via remodelling the tumor extracellular matrix","volume":"218","author":"Xu","year":"2026","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"114565","DOI":"10.1016\/j.colsurfb.2025.114565","article-title":"A novel NIR-dependent IDO-inhibiting ethosomes treatment melanoma through PTT\/PDT\/immunotherapy synergy","volume":"251","author":"Sun","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/bs.acr.2026.01.015","article-title":"Chapter Fourteen\u2014Futuredirections in nanotechnology for skin cancer","volume":"Volume 169","author":"Manglic","year":"2026","journal-title":"Advances in Cancer Research"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Tian, E., Zhang, Y., Wang, R., Wu, H., Sun, M., Yan, Y., She, L., and Ma, Z. (2026). MnO2-incorporated magnetic nanoparticles with pH-responsive drug release enhance hypoxia-resistant photodynamic therapy for melanoma. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18050586"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"25830","DOI":"10.1021\/acsnano.5c04580","article-title":"Oxygen-generating transdermal nanoplatform codelivering BRD4 proteolysis-targeting chimera\/verteporfin\/CaO2 synergistically remodels immunosuppressive melanoma microenvironment to potentiate combination immunotherapy","volume":"19","author":"Wei","year":"2025","journal-title":"ACS Nano"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"137291","DOI":"10.1016\/j.jcis.2025.137291","article-title":"H2O2\/O2 self-supplied nanoplatform for amplifying oxidative stress to accelerate photodynamic\/chemodynamic therapy cycles","volume":"690","author":"Xi","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Li, X., Gao, Y., Xing, Z., Liu, Z., and Zhang, X. (2025). Iron, copper and disulfide dysregulation: Molecular crossroads of metabolic cell death in melanoma progression. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1685331"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1039\/D1CS01079D","article-title":"New guidelines and definitions for type I photodynamic therapy","volume":"54","author":"Li","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/jacsau.5c01016","article-title":"Organic heterojunction nanoparticles: Photoinduced charge transfer and melanin-amplified ROS generation for melanoma photodynamic therapy","volume":"6","author":"Jin","year":"2026","journal-title":"JACS Au"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00604-026-07989-6","article-title":"Engineering organic, inorganic, carbon, and hybrid materials for skin cancer theragnostic: A focus on melanoma and non-melanoma","volume":"193","author":"Murugan","year":"2026","journal-title":"Mikrochim. Acta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"rbae019","DOI":"10.1093\/rb\/rbae019","article-title":"MRI-guided photothermal\/photodynamic immune activation combined with PD-1 inhibitor for the multimodal combination therapy of melanoma and metastases","volume":"11","author":"Wu","year":"2024","journal-title":"Regen. Biomater."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"058001","DOI":"10.1117\/1.JBO.31.5.058001","article-title":"Composing drug delivery with light distribution improvement: The use of dissolving microneedles in skin cancer with photodynamic therapy","volume":"31","author":"Requena","year":"2026","journal-title":"J. Biomed. Opt."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Stucchi, F., Li, M., Castellano, G., and Cellesi, F. (2026). Regulatory framework for polymer-based nanotherapeutics in clinical translation. Front. Bioeng. Biotechnol., 14.","DOI":"10.3389\/fbioe.2026.1735885"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"105054","DOI":"10.1016\/j.etap.2026.105054","article-title":"The long and winding nano-road: A review of toxicity, uncertainty, and regulation in nanomedicine","volume":"125","author":"Coral","year":"2026","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ma, S., Shi, S., Hu, X., Zhao, Y., Yang, B., Liao, M., Lu, B., and Xu, Q. (2025). From basic to clinical translation: Advances and perspectives of photodynamic nanodrugs. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1606372"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1080\/17435889.2026.2705388","article-title":"Navigating the translational valley of death in oncology nanotheranostics: Manufacturing, biological, clinical, and regulatory barriers to implementation","volume":"21","author":"Alum","year":"2026","journal-title":"Nanomedicine"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Li, C., Zhu, L., Wang, Y., Zhao, L., Lin, X., Sun, Z., Yan, T., Wang, Y., Piao, J., and Jin, A. (2026). Spatiotemporal control of immunogenic cell death: Rewiring tumor-immune dialogues for next-generation immunotherapy. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1784935"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","article-title":"DAMPs in the immunogenicity of cell death","volume":"85","author":"Chen","year":"2025","journal-title":"Mol. Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"25067","DOI":"10.1039\/D6RA01921H","article-title":"Photo-immunotherapeutic PDA-Ce6-R837 nanoparticles enhance the induction of immunogenic responses in melanoma cells","volume":"16","author":"Wang","year":"2026","journal-title":"RSC Adv."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e000337","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/bs.mcb.2023.05.003","article-title":"Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies","volume":"183","author":"Mishchenko","year":"2024","journal-title":"Methods Cell Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10103-026-04849-w","article-title":"Photodynamic therapy with zinc phthalocyanine suppresses immune checkpoints in human melanoma cells","volume":"41","author":"Doustvandi","year":"2026","journal-title":"Lasers Med. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.actbio.2025.07.035","article-title":"Mitochondria-targeting pseudo-stealthy nanophotosensitizer as a potent immunogenic cell death inducer to unleash the cancer-immunity cycle for melanoma therapy","volume":"203","author":"Shi","year":"2025","journal-title":"Acta Biomater."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/17435889.2025.2592970","article-title":"Advancing melanoma treatment with nanoparticles: From chemotherapy to combination therapies","volume":"21","author":"Hsu","year":"2026","journal-title":"Nanomedicine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11634","DOI":"10.1021\/acsami.4c18469","article-title":"Engineering a self-delivery nanoplatform for chemo-photodynamic-immune synergistic therapies against aggressive melanoma","volume":"17","author":"Wu","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"101311","DOI":"10.1016\/j.jpha.2025.101311","article-title":"Targeted reduction-responsive nanovehicles for photodynamic therapy-primed immunotherapy in melanoma","volume":"15","author":"Feng","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.actbio.2026.06.022","article-title":"G-quadruplex-modulated nanoplatform triggers a Ca2+ storm via the mitochondria-associated endoplasmic reticulum membrane for anti-melanoma multimodal therapy","volume":"218","author":"Yang","year":"2026","journal-title":"Acta Biomater."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Huang, C., Phann, T.T., OuYang, F., Zhou, D., Guo, P., Wang, Y., Huang, Y., Zeng, T., Gao, Q., and Wei, H. (2026). PD1 cell membrane-coated Ru(II)-Pt(IV) complex nanoparticles inhibit liver metastatic melanoma via cascade immune activation. J. Nanobiotechnol., 24.","DOI":"10.1186\/s12951-026-04167-x"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1039\/D5TB02242H","article-title":"Photo-immuno nano-bomb for co-delivery of Ce6 and R837 potentiates immunogenic cell death and amplifies anti-tumor efficacy in cutaneous squamous cell carcinoma","volume":"14","author":"Zhang","year":"2026","journal-title":"J. Mater. Chem. B"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41392-025-02542-y","article-title":"Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform","volume":"11","author":"Yang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"36129","DOI":"10.1021\/acsnano.5c04323","article-title":"2240 nm NIR-IV photodynamic therapy can reverse ineffective anti-OX40 cancer immunotherapy to become effective","volume":"19","author":"Shanmugam","year":"2025","journal-title":"ACS Nano"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e2414592","DOI":"10.1002\/advs.202414592","article-title":"A porphyrin nanomaterial for photoimmunotherapy for treatment of melanoma","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"101387","DOI":"10.1016\/j.mtbio.2024.101387","article-title":"AIEgen-self-assembled nanoparticles with anti-PD-L1 antibody functionalization realize enhanced synergistic photodynamic therapy and immunotherapy against malignant melanoma","volume":"30","author":"Li","year":"2024","journal-title":"Mater. Today Bio"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1038\/s41598-023-38862-8","article-title":"Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming","volume":"13","author":"Lobo","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_93","first-page":"310","article-title":"Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis","volume":"25","author":"Khan","year":"2026","journal-title":"EXCLI J."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"113726","DOI":"10.1016\/j.jconrel.2025.113726","article-title":"Soluble-microneedle enhance three T-cell activation signals as efficient tumor vaccines for melanoma prevention and treatment","volume":"383","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1021\/acsabm.4c02004","article-title":"Noninvasive transdermal delivery of STING agonists reshapes the immune microenvironment of melanoma and potentiates checkpoint blockade therapy efficacy","volume":"8","author":"Zhang","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e012856","DOI":"10.1136\/jitc-2025-012856","article-title":"Reprogramming the melanoma tumor immune microenvironment via combinatorial signal 2\/3 gene delivery","volume":"14","author":"Luly","year":"2026","journal-title":"J. Immunother. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/s41467-023-37656-w","article-title":"Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jare.2024.05.017","article-title":"Design of a targeted dual drug delivery system for boosting the efficacy of photoimmunotherapy against melanoma proliferation and metastasis","volume":"71","author":"Chen","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Luo, B., and Qiu, L. (2026). Nanovesicles with mechanically induced adjuvanticity for robust melanoma vaccination toward tumor-associated macrophages. Adv. Sci., e76773.","DOI":"10.1002\/advs.76773"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"34659","DOI":"10.1021\/jacs.5c09791","article-title":"An activatable and covalent tumor-associated antigen capturer enabling systemic injection in vivo for promoted antitumor immunity","volume":"147","author":"Gao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.7150\/thno.113417","article-title":"Phase-specific and laser-modulated polydopamine-chlorella-curdlan hydrogels: Pioneering a melanoma integrative therapy","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"114281","DOI":"10.1016\/j.jconrel.2025.114281","article-title":"Melanoma MHC-I-membrane-encapsulated Cu@ferrihydrite induces ferroptosis\/cuproptosis and systematic immunity against tumor","volume":"388","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"12261","DOI":"10.1021\/acsnano.4c00844","article-title":"Light-triggered nanozymes remodel the tumor hypoxic and immunosuppressive microenvironment for ferroptosis-enhanced antitumor immunity","volume":"18","author":"Fan","year":"2024","journal-title":"ACS Nano"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41551-025-01518-1","article-title":"A HO-1 gene knockout using a NanoCRISPR scaffold suppresses metastasis in mouse models","volume":"10","author":"Wang","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2147\/IJN.S503753","article-title":"Magnetic microbubbles combined with ICG-loaded liposomes for synergistic mild-photothermal and ferroptosis-enhanced photodynamic therapy of melanoma","volume":"20","author":"Xiong","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2147\/IJN.S502089","article-title":"A multifunctional MIL-101-NH2(Fe) nanoplatform for synergistic melanoma therapy","volume":"20","author":"Shang","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Li, H., Dou, Y., Yang, H., Xing, H., Zhu, C., Wang, T., Xuan, Z., and Yang, M. (2024). Ce6-modified Fe ions-doped carbon dots as multifunctional nanoplatform for ferroptosis and photodynamic synergistic therapy of melanoma. J. Nanobiotechnol., 22.","DOI":"10.1186\/s12951-024-02346-2"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/jdv.19897","article-title":"European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization","volume":"38","author":"Kandolf","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2011.10613.x","article-title":"Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: Results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo","volume":"166","author":"Dirschka","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjd.14498","article-title":"A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA versus placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy when using the BF-RhodoLED lamp","volume":"175","author":"Reinhold","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/jdv.20452","article-title":"Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED lamp","volume":"39","author":"Reinhold","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_112","first-page":"309","article-title":"A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel versus methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy","volume":"179","author":"Morton","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"104432","DOI":"10.1016\/j.pdpdt.2024.104432","article-title":"Long-term outcome of photodynamic therapy with hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate for low-risk basal cell carcinomas","volume":"51","author":"Salmivuori","year":"2025","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jaad.2025.12.034","article-title":"Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in the treatment of Bowen\u2019s disease: Long-term results of a multicenter randomized controlled trial","volume":"94","author":"Moermans","year":"2026","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2024.11.006","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Amaral","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"105584","DOI":"10.1016\/j.pdpdt.2026.105584","article-title":"Advances in enhancing photodynamic therapy for actinic keratoses and field-damage with laser pretreatments: A scoping review","volume":"60","author":"Boostani","year":"2026","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Pan, J., Wang, Y., Chen, Y., Zhang, C., Deng, H., Lu, J., and Chen, W. (2025). Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems. J. Nanobiotechnol., 23.","DOI":"10.1186\/s12951-025-03209-0"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/mp.17613","article-title":"AAPM Task Group Report 274: Fluence rate dosimetry for photodynamic therapy (PDT)","volume":"52","author":"Zhu","year":"2025","journal-title":"Med. Phys."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8723\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T04:12:16Z","timestamp":1791691936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":118,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198723"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198723","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}